drugset / Trial / NCT00210080

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

NCT00210080 ↗

Phase 3 Completed 700 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to determine if more diagnoses of lung cancer are obtained from the cytological evaluation of sputum expectorated following a single inhaled dose of UTP compared to sputum expectorated following a single inhaled dose of placebo in patients suspected of having lung cancer.

Timeline

Start
2001-04
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Uridine 5'-Triphosphate Unknown — Inhaled

Indications